Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in osteoblasts

被引:78
|
作者
Takami, M
Takahashi, N
Udagawa, N
Miyaura, C
Suda, K
Woo, JT
Martin, TJ
Nagai, K
Suda, T
机构
[1] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan
[2] Tokyo Inst Technol, Dept Bioengn, Yokohama, Kanagawa 2268501, Japan
[3] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biochem, Tokyo 1920392, Japan
[4] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1210/en.141.12.4711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) produced by osteoblasts/stromal cells are involved as positive and negative regulators in osteoclast formation. Three independent signals have been proposed to induce RANKL expression in osteoblasts/stromal cells: vitamin D receptor-, cAMP-, and gp130-mediated signals. We previously reported that intracellular calcium-elevating compounds such as ionomycin, cyclopiazonic acid, and thapsigargin induced osteoclast formation in cocultures of mouse bone marrow cells and primary osteoblasts. Increases in calcium concentration in culture medium also induced osteoclast formation in cocultures. Treatment of primary osteoblasts with these compounds or with high calcium medium stimulated the expression of both RANKL and OPG messenger RNAs (mRNAs). 1,2-Bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid)-tetra(acetoxymethyl)ester, an intracellular calcium chelator, suppressed both ionamycin-induced osteoclast formation in cocultures and expression of RANKL and OPG mRNAs in primary osteoblasts. Phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C, also stimulated osteoclast formation in these cocultures and the expression of RANKL and OPG mRNAs in primary osteoblasts. Protein kinase C inhibitors such as calphostin and staurosporin suppressed ionomycin- and PMA-induced osteoclast formation in cocultures and expression of RANKL and OPG mRNAs in primary osteoblasts. Ionomycin stimulated RANKL mRNA expression in ST2 and MC3T3-G2/PA6 cells, but not in MC3T3-E1 or NIH-3T3 cells. These effects were closely correlated with osteoclast formation in response to ionomycin in cocultures with these stromal cell lines. OPG strongly inhibited osteoclast formation induced by calcium-elevating compounds and PMA in cocultures, suggesting that RANKL expression in osteoblasts is a rate-limiting step for osteoclast induction. Forskolin, an activator of cAMP signals, also stimulated osteoclast formation in cocultures. Forskolin enhanced RANKL mRNA expression but suppressed OPG mRNA expression in primary osteoblasts. These results suggest that the calcium/protein kinase C signal in osteoblasts/stromal cells is the fourth signal for inducing RANKL mRNA expression, which, in turn, stimulates osteoclast formation.
引用
收藏
页码:4711 / 4719
页数:9
相关论文
共 50 条
  • [21] Roles of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in periodontal health and disease
    Nagasawa, Toshiyuki
    Kiji, Makoto
    Yashiro, Reiko
    Hormdee, Doosadee
    He, Lu
    Kunze, Melanie
    Suda, Tomonari
    Koshy, Geena
    Kobayashi, Hiroaki
    Oda, Shigeru
    Nitta, Hiroshi
    Ishikawa, Isao
    PERIODONTOLOGY 2000, 2007, 43 : 65 - 84
  • [22] The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
    Vega, Damaris
    Maalouf, Naim M.
    Sakhaee, Khashayar
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4514 - 4521
  • [23] Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts
    Wada, Yoshiyuki
    Mizuno, Morimichi
    Tamura, Masato
    ARCHIVES OF ORAL BIOLOGY, 2009, 54 (04) : 306 - 312
  • [24] The role of the receptor activator of nuclear factor-κB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism
    Nakchbandi, Inaam A.
    Lang, Robert
    Kinder, Barbara
    Insogna, Karl L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03): : 967 - 973
  • [25] Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
    Trouvin, Anne-Priscille
    Goeb, Vincent
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 345 - 354
  • [26] Serum levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand as markers of periprosthetic osteolysis
    Granchi, Donatella
    Pellacani, Andrea
    Spina, Mauro
    Cenni, Elisabetta
    Savarino, Lucia Maria
    Baldini, Nicola
    Giunti, Armando
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (07): : 1501 - 1509
  • [27] Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
    Deyama, Y
    Kikuiri, T
    Ohnishi, G
    Feng, YG
    Takeyama, S
    Hatta, M
    Yoshimura, Y
    Suzuki, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (02) : 240 - 246
  • [28] Nitric oxide regulates receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in bone marrow stromal cells
    Fan, X
    Roy, E
    Zhu, LP
    Murphy, TC
    Ackert-Bicknell, C
    Hart, CM
    Rosen, C
    Nanes, MS
    Rubin, J
    ENDOCRINOLOGY, 2004, 145 (02) : 751 - 759
  • [29] Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts
    Zhang, Yuanyu
    Liu, Xia
    Li, Kun
    Bai, Jingping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (03) : 919 - 924
  • [30] Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures
    Lee, SK
    Lorenzo, JA
    BONE, 2002, 31 (01) : 252 - 259